WebDisclosure WebDisclosure
Basculer en Français
10161 Companies
208736 Keywords
138859 Articles
110648 Press releases
Headlines Articles Press releases Emmecell Remove
  1. Home
  2. Companies
  3. Emmecell
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 04/30/2024 at 13:05, 1 year 11 months ago

    Emmecell Completes Final Cell Therapy Dosing in U.S. Clinical Trial for Corneal Edema

    Clinical Trial Cell Therapy Emmecell Corneal Edema Non-surgical Treatment
  • BRIEF

    published on 04/30/2024 at 13:05, 1 year 11 months ago

    Emmecell achève le dosage final de la thérapie cellulaire dans le cadre d'un essai clinique américain sur l'œdème cornéen

    Thérapie Cellulaire Essai Clinique Emmecell Œdème Cornéen Traitement Non Chirurgical
  • PRESS RELEASE

    published on 04/30/2024 at 13:00, 1 year 11 months ago

    Emmecell Completes Final Cell Therapy Dosing in U.S. Clinical Trial for Corneal Edema

    Emmecell completes final dose administration for the last patient in U.S. trial for EO2002, a non-surgical cell therapy for corneal edema, showing promise for treating vision loss
    Clinical Trial Cell Therapy Emmecell Corneal Edema EO2002
    Logo of Emmecell
Accesswire
  • Published on 04/02/2026 at 22:00, 2 days 1 hour ago

    Star Copper Announces Closing of Charity Flow-Through Unit Private Placement

  • Published on 04/02/2026 at 18:32, 2 days 5 hours ago

    Datavault AI CEO Nathaniel Bradley to Present DataValue(R), DataScore(R), and Information Data Exchange(R) Technologies at XRP Tokyo 2026

  • Published on 04/02/2026 at 15:00, 2 days 8 hours ago

    Jaguar Health Family Company Napo Pharmaceuticals Co-Sponsoring Pediatric Gastroenterology Conference: Elite Ped-GI Congress

  • Published on 04/02/2026 at 14:40, 2 days 8 hours ago

    Northfield Capital Completes Acquisition Of Additional Interest In Juno Corp. And Announces Issuance Of Class B Multiple Voting Shares

  • Published on 04/02/2026 at 14:30, 2 days 9 hours ago

    Worksport Announces COR(TM) Portable Energy System Is Now Fully Certified, Including Key UL and CSA Approvals, for North American Retail and Commercial Distribution

View all ACCESSWIRE
EQS Group
  • Published on 04/04/2026 at 10:07, 13 hours 29 minutes ago

    Heidelberg Pharma to Present Data from its ADC Technology Platform at AACR Annual Meeting 2026

  • Published on 04/04/2026 at 02:05, 21 hours 31 minutes ago

    Blokees made its debut at 2026 Thailand Toy Expo, exhibiting multiple products

  • Published on 04/03/2026 at 18:00, 1 day 5 hours ago

    IEVA GROUP: IMPLEMENTATION OF A LIQUIDITY AGREEMENT WITH CREDIT INDUSTRIEL ET COMMERCIAL

  • Published on 04/03/2026 at 18:00, 1 day 5 hours ago

    IEVA GROUP: MISE EN OEUVRE D’UN CONTRAT DE LIQUIDITE AVEC LE CREDIT INDUSTRIEL ET COMMERCIAL

  • Published on 04/03/2026 at 17:45, 1 day 5 hours ago

    Atbash Launches on Chromia to Enable Verifiable, User-Controlled AI Systems

View all EQS
Les Echos
  • Published on 04/03/2026 at 18:46, 1 day 4 hours ago

    Disclosure of Share Capital and Voting Rights as of March 31, 2026

  • Published on 04/03/2026 at 18:46, 1 day 4 hours ago

    Déclaration du nombre d’actions et droits de vote au 31 mars 2026

  • Published on 04/03/2026 at 18:01, 1 day 5 hours ago

    ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL

  • Published on 04/03/2026 at 18:00, 1 day 5 hours ago

    ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL

  • Published on 04/03/2026 at 18:00, 1 day 5 hours ago

    LANSON-BCC : Déclaration du nombre total des droits de vote et du nombre d’actions au 31 mars 2026

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2026 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy